Expect to See Subcutaneous Methotrexate for Rheumatoid Arthritis

April 2018

You'll see more methotrexate options for rheumatoid arthritis.

Oral methotrexate is still first-line for most rheumatoid arthritis patients. But it can be hard to tolerate...making it tempting to go to other DMARDs (sulfasalazine, etc) or biologics (Humira, etc) too soon.

Evidence suggests SUBCUTANEOUS methotrexate may have fewer GI side effects than oral and be more effective because it's better absorbed...especially at doses of 15 mg or more per week.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote